Precision Oncology Through Diagnostic Imaging and Theranostics

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".

Deadline for manuscript submissions: 31 July 2026 | Viewed by 9

Special Issue Editors

Department of Medical Education, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale-Davie, FL, USA
Interests: molecular imaging; chemical probes; reactive oxygen species; oxidative stress; cell death; nanomedicine; target-ed drug delivery; retinal ganglion cells; traumatic optic neuropathy; cancer biology; precision medicine
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Medicine, North Alabama Medical Center, Florence, AL, USA
Interests: cancer biology; cancer diagnostics; sarcoma; IDH mutations; translational oncology; targeted therapy; epigenetic modifiers; drug discovery and screening; precision medicine; tumor metabolis

E-Mail Website
Guest Editor
Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL, USA
Interests: cancer diagnostics; cancer therapy; nanotechnology

Special Issue Information

Dear Colleagues,

Cancer remains one of the leading causes of mortality worldwide, and early, accurate diagnosis is critical for improving patient outcomes. Recent progress in diagnostic imaging has transformed the detection, staging, and monitoring of cancers, while the emergence of theranostics, which combines diagnostic and therapeutic strategies, has opened new opportunities for precision oncology. Molecular imaging, radiomics, and artificial intelligence allow visualization of tumor biology at the cellular and molecular levels, facilitating personalized treatment planning and the real-time evaluation of therapeutic responses.

This Special Issue aims to highlight current advances in cancer diagnostic imaging and theranostics, covering both fundamental discoveries and translational applications. Areas of interest include novel imaging probes and radiotracers, image-guided therapy, nanotheranostics, multimodal imaging, and imaging biomarkers for treatment prediction and monitoring. Studies that integrate imaging technologies with molecular biology, pharmacology, immunotherapy, or targeted drug delivery are particularly welcome.

By bridging innovation from laboratory research to clinical application, this Special Issue provides a platform for researchers, clinicians, and industry experts to share insights that drive the development of effective, individualized cancer management strategies. We invite original research, comprehensive reviews, and methodological studies that advance the understanding and application of diagnostic imaging and theranostics in oncology.

Dr. Wensi Tao
Dr. Luyuan Li
Dr. Yu-Ping Yang
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer imaging
  • molecular imaging
  • theranostics
  • nanomedicine
  • imaging biomarkers
  • precision oncology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop